Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios

Objectives Treatment for advanced renal cell carcinoma (RCC) has become increasingly more complex over the last several years. Objective 1 is to which treatment option is immunotherapy, targeted therapy, or the combination of immunotherapy with targeted therapy the best for patients? Objective 2 is...

Full description

Saved in:

Bibliographic Details
Published in:	International urology and nephrology Vol. 51; no. 12; pp. 2107 - 2117
Main Authors:	Cetin, Bulent, Kosar, Alim
Format:	Journal Article
Language:	English
Published:	Dordrecht Springer Netherlands 01.12.2019 Springer Nature B.V
Subjects:	Aged Carcinoma, Renal Cell - therapy Clear cell-type renal cell carcinoma Clinical trials Clinical Trials as Topic Decision making Drug development Female Humans Immune checkpoint inhibitors Immunotherapy Kidney cancer Kidney Neoplasms - therapy Male Medicine Medicine & Public Health Metastases Metastasis Middle Aged Molecular Targeted Therapy Monoclonal antibodies Nephrology Patients Risk groups Targeted cancer therapy Tyrosine Urology Urology - Review Vascular endothelial growth factor Metastatic renal cell carcinoma Immunotherapy Tyrosine kinase inhibitors
ISSN:	0301-1623, 1573-2584, 1573-2584
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!